Creatine is the best-evidenced supplement available to women in midlife, and the claim most often made for it — that it builds bone — is the one the evidence does not support. Both halves of that sentence matter. Here is what the trials in this population actually found, the dose that produced it, and the two conditions without which it does nothing at all.
What creatine is
Your body makes it, and you eat it in red meat and fish. It is stored in muscle, where it helps regenerate the energy currency used in short, hard efforts. Women tend to have lower muscle creatine stores than men and lower dietary intake, which is the usual argument for why supplementing might matter more, not less, for us.
It is not a hormone, not a stimulant, and not a steroid. It is one of the most studied supplements in existence.
What the research in menopausal women actually found
A systematic review and meta-analysis pooled seven randomized controlled trials in postmenopausal women — 608 participants, trials running from 12 weeks to two years. The findings, stated plainly:
- Lean mass increased by about 0.37 kg on average. Small, real, and worth having when the alternative is a steady decline.
- Leg press strength improved by around 7.5 kg on the one-repetition maximum.
- Bone density was unchanged overall. This is the important one. Creatine is widely marketed to midlife women on a bone story, and the pooled evidence does not show a reliable increase in bone mineral density at the sites that matter clinically.
- No evidence of harm across the trials.
The two conditions
This is where most people get nothing for their money, and the meta-analysis is unusually clear about it.
- It has to be at least 5 g a day. Trials using 3 g or less did not produce a measurable effect.
- It has to be paired with resistance training. The benefit appeared where creatine was combined with lifting. Taking it without training was where the null results came from.
Creatine is not a thing you take instead of training. It is a thing that makes training pay slightly better. If you are not lifting, save your money until you are.
One honest caveat about the population
Most of this research is in postmenopausal women, at a mean age of around 62. Perimenopausal women in their forties are less well studied. The mechanism should carry across — falling lean mass is the same problem earlier — but it is an extrapolation, and anyone telling you there is a large perimenopause-specific evidence base is overstating it.
How to take it
- Creatine monohydrate. That is the form used in essentially all the research. Micronized monohydrate is the same thing ground finer, which helps it mix; that is fine. HCl, buffered and "advanced" forms cost more and have no demonstrated advantage.
- 5 g a day, every day. Consistency matters far more than timing — muscle stores fill over weeks. There is no need to take it before training rather than after.
- You do not need a loading phase. Loading fills stores in about a week instead of three or four. It also causes most of the stomach upset people report. Skip it.
- Take it with food or split the dose if 5 g at once bothers your stomach.
- Look for third-party testing. Monohydrate is cheap and unglamorous, which is exactly why quality varies.
The scale will go up. That is not fat.
Expect one to two pounds in the first couple of weeks. Creatine draws water into muscle cells — it is intracellular, not the puffy subcutaneous kind, and it is the mechanism working rather than a side effect.
This is the single most common reason women stop taking creatine, usually within three weeks, which is before any of the benefit above has had time to appear. If you track anything, track waist and what you can lift, not weight. We went through why in perimenopause belly fat.
Safety, and the two rumors
- Kidneys. Creatine has been studied for decades and does not damage kidney function in healthy people. It does raise blood creatinine slightly, which can look like a red flag on a routine test — tell whoever ordered the test that you take it. If you have existing kidney disease, this is a conversation with your clinician first.
- Hair loss. This traces back to a single small study in rugby players in 2009 that measured a hormone marker, not hair, and has not been replicated since. It is one of the most repeated claims in the category and one of the least supported.
- Bloating. Mostly a loading-phase phenomenon. Skip loading and it is uncommon.
The interesting part that is still early
There is emerging work on creatine and cognition, specifically under sleep deprivation — the brain uses creatine too, and stressing the system seems to be where a difference shows up. Given what perimenopausal sleep does, this is a genuinely interesting thread.
It is also early, the studies are small, and we are not going to build a claim on it. File it under worth watching.
What creatine is not
It is not a weight-loss supplement — nothing above is a fat-loss mechanism. It is not a bone treatment, whatever the packaging says. And it is not a replacement for protein; the two do different jobs, and protein is the more fundamental of the pair.
The short version
- Seven RCTs in postmenopausal women: lean mass up about 0.37 kg, leg press up about 7.5 kg, no harm.
- Bone density was unchanged. Do not buy creatine for your bones.
- 5 g a day minimum, and it only worked alongside resistance training.
- Monohydrate. No loading phase. Consistency over timing.
- The first two pounds are water inside muscle. Do not quit over it.
- Safe in healthy people; mention it if you are having kidney bloods done.
- Most of the evidence is postmenopausal, mean age 62 — perimenopause is an extrapolation.
This article is general information, not medical advice. Talk to a clinician before starting creatine if you have kidney disease or are pregnant or breastfeeding. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
